- Home
- FGEN vs XOS Comparison
FGEN vs XOS Comparison
Compare FGEN & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- XOS
- Stock Information
- Founded
- FGEN 1993
- XOS 2016
- Country
- FGEN United States
- XOS United States
- Employees
- FGEN N/A
- XOS N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- XOS Construction/Ag Equipment/Trucks
- Sector
- FGEN Health Care
- XOS Consumer Discretionary
- Exchange
- FGEN Nasdaq
- XOS Nasdaq
- Market Cap
- FGEN 33.5M
- XOS 25.6M
- IPO Year
- FGEN 2014
- XOS N/A
- Fundamental
- Price
- FGEN $7.26
- XOS $3.49
- Analyst Decision
- FGEN Strong Buy
- XOS Buy
- Analyst Count
- FGEN 1
- XOS 5
- Target Price
- FGEN $250.00
- XOS $8.80
- AVG Volume (30 Days)
- FGEN 74.1K
- XOS 17.6K
- Earning Date
- FGEN 08-05-2025
- XOS 08-12-2025
- Dividend Yield
- FGEN N/A
- XOS N/A
- EPS Growth
- FGEN N/A
- XOS N/A
- EPS
- FGEN N/A
- XOS N/A
- Revenue
- FGEN $6,996,000.00
- XOS $48,678,000.00
- Revenue This Year
- FGEN N/A
- XOS $1.45
- Revenue Next Year
- FGEN N/A
- XOS $27.16
- P/E Ratio
- FGEN N/A
- XOS N/A
- Revenue Growth
- FGEN N/A
- XOS N/A
- 52 Week Low
- FGEN $4.50
- XOS $2.73
- 52 Week High
- FGEN $38.25
- XOS $9.15
- Technical
- Relative Strength Index (RSI)
- FGEN 60.54
- XOS 66.03
- Support Level
- FGEN $5.37
- XOS $3.17
- Resistance Level
- FGEN $5.73
- XOS $3.50
- Average True Range (ATR)
- FGEN 0.49
- XOS 0.13
- MACD
- FGEN 0.27
- XOS 0.06
- Stochastic Oscillator
- FGEN 83.80
- XOS 98.00
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About XOS Xos Inc.
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.